Co-prescribing of linezolid and serotonergic agents in a general hospital setting.
Co-prescription of linezolid and serotonergic agents (SSRIs, SNRIs, NaSSA, TCAs) can lead to serotonin syndrome, this study seeks to identify prescribing practise of these agents. Study of all general hospital inpatients prescribed intravenous linezolid in a 3-month period, using drug charts and clinical notes. Co-prescription occurred in 20% with SSRIs most frequently concurrently used. There were no cases of serotonin syndrome. There was no evidence in clinical notes of vigilance for potential interaction. Co-prescription is common; awareness of potentially serious interaction is not evident in current practice.